- Home
- Cardiology
Dapagliflozin in HFmrEF and HFpEF: Insights from the DELIVER Trial
20233 min read
Medical Article
Heart failure (HF) poses a substantial health challenge, with patients often experiencing recurrent hospitalizations that significantly contribute to the overall disease burden. While mortality risk diminishes with increasing ejection fraction (EF), the frequency of HF-related hospitalizations remains relatively constant across EF spectrums. This i

Dapagliflozin in HFmrEF and HFpEF: Insights from the DELIVER Trial
1984 Reached5 Comments
Similar Content

Case of Pulmonary Embolism with Syncope
544 Reached4 Likes

CT Angiography of Spontaneous Coronary Artery Dissection
4208 Reached15 Comments13 Likes

ACC, AHA and ESC Recommendations for Heart Failure Management
2323 Reached29 Comments2 Likes

Shoulder Dislocation during Swimming
78 Reached9 Comments18 Likes

Plastic Bronchitis in an Infant
449 Reached
